The Interplay Between Human Leukocyte Antigen Antibody Profile and COVID-19 Vaccination in Waitlisted Renal Transplant Patients

CONCLUSIONS.—: Our data suggest that COVID-19 vaccination propagates anti-HLA class I and II antibodies for waitlisted renal transplant patients. The clinical significance of these antibodies needs further study. Furthermore, comorbidities, such as history of COVID-19 infection and hypertension, supplemented this effect. Anti-HLA antibody monitoring may be warranted in vaccinated, waitlisted renal transplant patients with COVID-19 vaccinations, and a history of COVID-19 infection or hypertension.PMID:38599589 | DOI:10.5858/arpa.2023-0370-OA

Source: Archives of Pathology and Laboratory Medicine - April 10, 2024 Category: Laboratory Medicine Authors: Yayuan Zhao Pramath Kakodkar Henry Pan Richard Zhu Khalid Musa Abubaker Hassan Ahmed Shoker Destinie Webster Twyla Pearce Pouneh Dokouhaki Fang Wu Ahmed Mostafa Source Type: research